UK markets open in 4 hours 24 minutes
NIKKEI 225
38,642.11 -61.40 (-0.16%) HANG SENG
18,441.37 -35.43 (-0.19%) CRUDE OIL
75.56 +0.01 (+0.01%) GOLD FUTURES
2,389.20 -1.70 (-0.07%) DOW
38,886.17 +78.84 (+0.20%) Bitcoin GBP
55,320.76 -352.75 (-0.63%)
BMY Sep 2024 42.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:52PM EDT. Market open.
| Previous close | 2.7500 |
| Open | 2.7500 |
| Bid | 2.9300 |
| Ask | 2.9900 |
| Strike | 42.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.7500 - 2.9700 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.98k |
Insider MonkeyHere’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list. Click to see the full list of 11 stocks Cramer is bearish on. In this article we will take a deeper look at BMY and find out whether Cramer’s thesis holds any weight. […]
ZacksBristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
© 2024 Yahoo. All rights reserved.